Coya Therapeutics, Inc. (COYA) Return on equity 2023–2025
Coya Therapeutics, Inc. (COYA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-49.3%FY2025 · since FY2023: -22.4% → -49.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -49.3% | -11.7 pp |
| FY2024 | -37.6% | -15.2 pp |
| FY2023 | -22.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More COYA financial trends
COYA RevenueCOYA Net incomeCOYA Net marginCOYA Gross profitCOYA Gross marginCOYA Operating incomeCOYA Operating marginCOYA Operating cash flowCOYA Free cash flowCOYA Capital expendituresCOYA Stock buybacksCOYA Dividends paidCOYA Total assetsCOYA Total liabilitiesCOYA Shareholders’ equityCOYA overview →